ND4 mutation in transitional cell carcinoma: Does mitochondrial mutation occur before tumorigenesis?

Area of Science:

• Oncology
• Genetics
• Mitochondrial Biology

Background:

• Mitochondrial DNA (mtDNA) mutations are implicated in cancer development.
• The precise timing and origin of mtDNA mutations in tumorigenesis remain unclear.

Purpose of the Study:

• To investigate the occurrence and origin of ND4 gene mutations in upper tract urothelial carcinomas (TCCs).
• To determine if mtDNA mutations are acquired during tumorigenesis or pre-exist.

Main Methods:

• Analysis of ND4 mutations in 53 TCCs and normal adjacent tissues.
• Utilized DNA sequencing, restriction fragment length polymorphism (RFLP), and denaturing high-performance liquid chromatography (DHPLC) for mutation detection.
• Compared mutation detection sensitivity across different methods.

Main Results:

• ND4 mutations were detected in 24.5% of tumors using sequencing and RFLP.
• DHPLC identified 11 of these mutations in corresponding normal tissues.
• Less sensitive methods failed to detect pre-existing minor mtDNA mutations in normal tissue.

Conclusions:

• Most detected mitochondrial ND4 mutations in TCCs pre-exist in normal tissues at low levels.
• mtDNA mutations appear to occur before cancer development (tumorigenesis) and become more apparent in cancer cells.
• This suggests mtDNA mutations are not solely acquired during cancer progression but may be an early event.